Role of diabetes and nitric oxide release duration on analytical performance of in vivo glucose biosensors
糖尿病和一氧化氮释放持续时间对体内葡萄糖生物传感器分析性能的作用
基本信息
- 批准号:10263316
- 负责人:
- 金额:$ 60.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ArchitectureBiological AssayBiosensorBlood GlucoseCell SurvivalCellular biologyChemicalsClinicalDataDependenceDevelopmentDevicesDiabetes MellitusDiseaseElectrospinningFDA approvedFamily suidaeFiberForeign BodiesFundingFutureGene Expression ProfilingGeneticGlucoseHealthHistocompatibilityImmune responseImpaired wound healingImplantIn VitroIndividualInsulinInsulin-Dependent Diabetes MellitusKnowledgeMediatingMembraneModificationMolecularMorphologyNitric OxideNitric Oxide DonorsPerformancePhasePolyurethanesPorosityProtocols documentationQuality of lifeReactionReportingResearchRoleSignal TransductionSilicon DioxideSulfhydryl CompoundsSystemSystems BiologyTestingThickTissuesVascularizationWorkbasebiomaterial compatibilitycapsuledesigndiabeticexpirationglucose monitorglucose sensorimplantationimplanted sensorimprovedin vivoin vivo evaluationmonitoring devicenext generationnon-diabeticparticleperformance testsporcine modelpreventresponsesensorusabilitywound healing
项目摘要
PROJECT SUMMARY
The objective of this project is to study the analytical performance benefits of nitric oxide (NO)-releasing
percutaneously implanted glucose sensors in a diabetic swine model as a function of NO-release duration sensor
membrane porosity, and diabetes state (i.e., insulin versus non-insulin dependent). Continuous glucose monitoring
(CGM) devices with superior usability (i.e., for immediate use and extended duration) would greatly increase the
ability of those afflicted with diabetes to successfully manage their disease. In the prior funding period, we
demonstrated in a non-insulin dependent diabetic swine model that NO-releasing sensor membranes both lessen the
FBR and facilitate improved analytical sensor performance up to 28 days—the longest duration evaluated. However,
CGM devices are intended for insulin-dependent individuals and longer implantation periods would improve device
utility/value. The variance in FBR and in vivo sensor performance for insulin- and non-insulin-dependent subjects is
currently unknown but likely significant due to more impaired wound healing mechanisms. We hypothesize that the
improvements in FBR and sensor performance that we have reported sensor membranes that release NO for 28 days
will be extended to at least two months by using porous sensor membranes that release for 60+ days and passively
promote healthy re-vascularization in the proximity of the sensor. Through our work, we will study the influence of
both NO release and porosity on tissue biocompatibility and sensor performance as a function of diabetes. In this
respect, we will generate new knowledge on how diabetes influences the tissue integration and in vivo sensor
performance.
项目摘要
该项目的目的是研究一氧化氮(NO)释放的分析性能益处
经皮植入糖尿病猪模型中的葡萄糖传感器作为无释放持续时间传感器的函数
膜孔隙度和糖尿病状态(即胰岛素与非胰岛素依赖性)。连续葡萄糖监测
(CGM)具有卓越可用性的设备(即立即使用和延长持续时间)将大大增加
患有糖尿病的人成功控制疾病的人的能力。在以前的资金期间,我们
在非胰岛素依赖性糖尿病猪模型中证明,不释放传感器机制都会降低
FBR并促进长达28天的分析传感器性能改善,这是评估最长的持续时间。然而,
CGM设备旨在用于胰岛素依赖性个体,较长的植入期将改善设备
实用程序/价值。胰岛素和非胰岛素依赖性受试者的FBR和体内传感器性能的差异是
目前未知,但由于伤口愈合机制的受损更大而可能很重要。我们假设
我们已经报告了传感器机制的FBR和传感器性能的改进,该机制释放了28天
通过使用释放60天以上的多孔传感器机制将至少扩展到两个月
在传感器的接近度中促进健康的重新血管化。通过我们的工作,我们将研究
在组织生物相容性和传感器性能上都没有释放和孔隙度随糖尿病的作用。在这个
尊重,我们将获得有关糖尿病如何影响组织整合和体内传感器的新知识
表现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark H Schoenfisch其他文献
Mark H Schoenfisch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark H Schoenfisch', 18)}}的其他基金
Nitric oxide-releasing hyaluronic acid therapeutics for treating periodontal disease
释放一氧化氮的透明质酸疗法用于治疗牙周病
- 批准号:
10657158 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Nitric oxide-releasing glycosaminoglycans for treating complex wounds
释放一氧化氮的糖胺聚糖用于治疗复杂伤口
- 批准号:
10584269 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Nitric oxide-releasing dendrimers for the treatment of periodontal disease
释放一氧化氮的树枝状聚合物用于治疗牙周病
- 批准号:
8927301 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Nitric oxide-releasing dendrimers for the treatment of periodontal disease
用于治疗牙周病的释放一氧化氮的树枝状聚合物
- 批准号:
9261511 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Role of diabetes and nitric oxide release duration on analytical performance of in vivo glucose biosensors
糖尿病和一氧化氮释放持续时间对体内葡萄糖生物传感器分析性能的作用
- 批准号:
10418787 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Role of diabetes and nitric oxide release duration on analytical performance of in vivo glucose biosensors
糖尿病和一氧化氮释放持续时间对体内葡萄糖生物传感器分析性能的作用
- 批准号:
9185309 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Role of diabetes and nitric oxide release duration on analytical performance of in vivo glucose biosensors
糖尿病和一氧化氮释放持续时间对体内葡萄糖生物传感器分析性能的作用
- 批准号:
10673705 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Nitric oxide-releasing dendrimers for the treatment of periodontal disease
释放一氧化氮的树枝状聚合物用于治疗牙周病
- 批准号:
9104134 - 财政年份:2015
- 资助金额:
$ 60.65万 - 项目类别:
Nitric oxide-releasing cystic fibrosis therapeutics
释放一氧化氮的囊性纤维化疗法
- 批准号:
8968231 - 财政年份:2014
- 资助金额:
$ 60.65万 - 项目类别:
相似国自然基金
MgO纳米带/BDD电极的制备及多组分同步测定生物传感机制研究
- 批准号:61401306
- 批准年份:2014
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
受激细胞释放ATP浓度分布的高灵敏度实时生物发光检测方法的研究
- 批准号:60974114
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
基于生物传感器的植物激素高灵敏原位实时测定技术研究
- 批准号:90817101
- 批准年份:2008
- 资助金额:200.0 万元
- 项目类别:重大研究计划
植物激素的高灵敏免疫传感测定仪研制
- 批准号:30670190
- 批准年份:2006
- 资助金额:31.0 万元
- 项目类别:面上项目
生物传感器BOD快速测定仪的研制
- 批准号:50327802
- 批准年份:2003
- 资助金额:120.0 万元
- 项目类别:专项基金项目
相似海外基金
MetabolGut: a rapid assay platform to evaluate the impact drugs on lipid-handlingpathways and chylomicron-associated drug distribution using stem cell-drivenhuman absorptive enterocytes.
MetabolGut:一个快速检测平台,使用干细胞驱动的人体吸收性肠上皮细胞来评估药物对脂质处理途径和乳糜微粒相关药物分布的影响。
- 批准号:
10766493 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
使用具有集成电化学适体传感器的微流体平台对显微解剖肿瘤进行多重药物测试
- 批准号:
10669408 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Development of A Novel Nanoparticle Biosensor for Rapid, Point-of-Care Sepsis Diagnosis and Risk Assessment
开发新型纳米颗粒生物传感器,用于快速护理点脓毒症诊断和风险评估
- 批准号:
10602155 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Development of Modular Synthetic Sensors for Protein Biomarker Detection
用于蛋白质生物标志物检测的模块化合成传感器的开发
- 批准号:
10659642 - 财政年份:2023
- 资助金额:
$ 60.65万 - 项目类别:
Affinity Reagents and Sensor Platform Development for Blood Biochemical Monitoring
用于血液生化监测的亲和试剂和传感器平台开发
- 批准号:
10452054 - 财政年份:2022
- 资助金额:
$ 60.65万 - 项目类别: